Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma × ProMune × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Melanoma 3 Breast Neoplasms 3 Uveal Melanoma 1 Skin Neoplasms 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Lung Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1 Breast Neoplasms, Male 1

Interventions

Cisplatin 19 Paclitaxel 15 Carboplatin 15 Gemcitabine 12 pembrolizumab 11 Fluorouracil 8 Specimen Handling 7 Radiotherapy 7 Nivolumab 6 Magnetic Resonance Spectroscopy 6 Docetaxel 6 cemiplimab 5 Sunitinib 5 Platinum 5 Oxaliplatin 5 Everolimus 5 Cyclophosphamide 5 Capecitabine 5 durvalumab 4 anlotinib 4 Radiotherapy, Intensity-Modulated 4 Pemetrexed 4 Drug Therapy 4 Cetuximab 4 1,2-diaminocyclohexaneplatinum II citrate 4 padeliporfin 3 epothilone B 3 atezolizumab 3 Panitumumab 3 Leucovorin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00070642 2009-02-10

CPG 7909 Injection in Melanoma

Pfizer

Phase 2 Completed

Carcinoma, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡